mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.08 |
mRNA |
SJ-172550 |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.09 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.09 |
mRNA |
MS-275 |
gCSI |
pan-cancer |
AAC |
-0.093 |
0.09 |
mRNA |
MLN2480 |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.09 |
mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.09 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.09 |
mRNA |
BRD-A02303741 |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.09 |
mRNA |
blebbistatin |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.09 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.1 |